{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-161572","form_type":"8-K","ticker":"NMRA","cik":"0001885522","company_name":"Neumora Therapeutics, Inc.","filed_at":"2024-06-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.091881+00:00","generated_at":"2026-06-01T04:26:36.085390+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Neumora stockholders elect Gosebruch and Burow as Class I directors, ratify EY as auditor","bullets":["Henry O. Gosebruch elected with 88,190,874 votes for, 2,313,739 withheld, and 12,544,469 broker non-votes.","Kristina Burow elected with 87,022,169 votes for, 3,482,444 withheld, and 12,544,469 broker non-votes.","Ratification of Ernst & Young as auditor for FY2024: 102,921,992 for, 123,868 against, 3,222 abstentions.","As of record date April 15, 2024, 159,452,584 shares were outstanding and entitled to vote."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-161572","json":"https://secwatch.observer/filing/0001193125-24-161572.json","markdown":"https://secwatch.observer/filing/0001193125-24-161572.md","text":"https://secwatch.observer/filing/0001193125-24-161572.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1885522/000119312524161572/0001193125-24-161572-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1885522/000119312524161572/d788157d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:26:36.085390+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}